Curaleaf Holdings (TSX:CURA) has pushed its hostile bid for Aurora Cannabis higher, lifting the implied offer to US$5 per share as it seeks a larger footprint in Canadian cannabis.
At around CA$14.06, Curaleaf Holdings has given investors a 30.91% year to date share price return, even though the 1 year total shareholder return of 3.46% and 5 year total shareholder return decline of 65.64% point to a story where near term momentum has picked up while longer term performance remains weak.
Compare Curaleaf Holdings with other potential cannabis consolidators by scanning our hand picked 9 high quality undiscovered gems that may be flying under most investors' radar.
The hostile Aurora bid and Curaleaf Holdings’ recent share price rebound now leave a clear gap between today’s CA$14.06 price and various value estimates. How wide is that gap once the numbers are lined up?
Curaleaf Holdings last closed at CA$14.06, while the most followed narrative pins fair value closer to CA$18.54. This frames the current hostile Aurora offer against a backdrop of perceived upside and execution risk.
Rapid expansion and regulatory breakthroughs in international markets, notably the strong sequential and yearly growth in Germany, new entry into Turkey (an 87-million-person underpenetrated market), and advancements such as the first medically certified EU device, meaningfully increase Curaleaf's total addressable market, diversify revenue streams beyond the saturated U.S. market, and are likely to drive sustained long-term revenue growth.
What is behind 17 investors see Curaleaf Holdings as 24% undervalued.
Analysts building this framework apply a 6.62% discount rate and arrive at a fair value of CA$18.54, which is about 24% above where Curaleaf Holdings trades today. Their view leans heavily on models that factor in forecast revenue of roughly US$1.7b, an 11.27% profit margin and a future P/E of about 24x, while also allowing for share count growth and ongoing losses over at least the next three years.
Result: Fair Value of CA$18.54 (UNDERVALUED)
Still, the Curaleaf Holdings story can break if pricing pressure keeps squeezing margins or if costly international expansion drags out losses longer than analysts expect.
Find out about the key risks to this Curaleaf Holdings narrative.
Mixed signals around Curaleaf Holdings can be useful if you move fast, pressure test the numbers yourself, then weigh 4 key rewards and 3 important warning signs
If Curaleaf Holdings has your attention today, use that momentum to review a few curated stock ideas that match different goals and risk levels.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com